Pr. Jean Claude MBANYA
Jean Claude Mbanya is Professor of Medicine and Endocrinology at the Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Director Biotechnology Center and Postgraduate Dean Doctoral School of Life Sciences, Health and Environmental Sciences, University of Yaoundé 1 and Adjunct Professor of Medicine, Endocrinology & Diabetes, at the University of Technology, Jamaica. He is also Consultant Physician and Director of the National Obesity Centre at the University Teaching Hospital in Yaoundé. He is Honorary President of the International Diabetes Federation. He initially studied in Cameroon where he obtained his MD and trained at the University of Newcastle upon Tyne, England where he obtained a PhD and later Member of the Royal College of Physicians. He is a Fellow of the Royal College of Physicians, London and Doctor philosophiae honoris causa, University of Oslo, Norway. His research interests are in the epidemiology of non-communicable diseases, especially diabetes and its complications, ethno-pharmacology and molecular biology of diabetes, hypertension, and thyroid diseases and their impact on the health care systems of developing countries. He has a wide span of expertise, but his current focus is on clinical application of basic research and equity of access to care and education and the integration of diabetes and endocrine diseases in the primary health care activities of developing countries. Output from this exceptional scientific research and service career has been published in 28 international book chapters and over 185 papers in peer-reviewed journals. His major interests include diabetes and other non-communicable diseases epidemiology and prevention, integration of diabetes care in the health care system of developing countries, diabetes complications, obesity and physical activity as risk factors of non-communicable diseases. Among numerous other outstanding achievements for diabetes, as President of the International Diabetes Federation (2009 – 2012) he championed the convening of the first ever United Nations High Level Summit on non-communicable diseases held in 2011. As Chairman of the HbA1c International Consensus Group (International Federation of Clinical Chemists, American Diabetes Association, European Association for the Study of Diabetes, and International Diabetes Federation), he managed the establishment of a global unified HbA1c reporting system during the introduction of more sensitive calibrators. As Chairman of the International Diabetes Federation Task Force on Insulin (1997 – 2012), he led the change to a unified colour code by all manufacturers of insulin for the different types of insulin. These outstanding achievements have been recognised widely around the world. Among others, he was the 2004 recipient of the American Diabetes Association Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes. In 2011 he was conferred the degree of ‘Doctor philosophiae honoris causa’ by the University of Oslo for significant scientific contribution and work of outstanding quality furthering the scientific endeavour. He is also Fellow Cameroon Academy of Sciences, Fellow of The Third World Academy of Sciences, Trieste, Italy and Senior Research Fellow International Prevention Research Institute, Lyon, France.